BCL2 and renal carcinoma: It is worth mentioning that previous studies have found that TEK knockdown can significantly promote AKT phosphorylation and inhibit the apoptosis of renal cancer cells by upregulating the downstream pro-apoptotic proteins Bcl-2 and Bcl-xL (Chen et al., 2021).